Moderna’s delivery of a COVID-19 vaccine comes on the heels of revolutionary science that may accelerate innovation across the industry well into the future.
Insights on Pharmaceuticals & Medical Products
How can biotechs and investors succeed in the future? To scale up innovation, industry stakeholders need to focus on several key areas.
Europe may be catching up with the United States in biotech innovation and funding. Its overall score on the Biotech Innovation Index improved by 20 percent in 2015–17 and 2018–20.
Europe’s biotech sector has made meaningful progress in attracting capital. However, raising more capital will be essential to the continued growth of this sector.
Europe is a powerhouse in scientific publishing with roughly twice the output of the United States and three times that of China.
We mapped out 1,382 biotechs based in Europe and some interesting themes emerged.
Cell and gene therapies are at the forefront of innovation and transforming how we treat and potentially cure certain diseases. What will the next decade hold for these life-changing therapies?
Anne Nijs explains how the rare-disease group at Roche Pharmaceuticals pioneered a new model that puts the patient experience at the center of healthcare innovation and delivery.
Poor mental health takes a heavy toll on individuals and businesses. New digital solutions can help employers provide personalized support and make well-being a strategic focus for their organization.
World-class science and innovation need to be matched with stronger scale-up capabilities and a broader funding base if Europe is to emerge as a leader in biotech.